Endocrinology · 2002 · 42 citations · 43 references
MedicineEndocrinologyMedicinal ChemistryBone MetabolismCalcium HomeostasisMineral MetabolismBone HealthBone Metabolism DisordersBone TissueMetabolic Bone DiseaseVitamin DVitamin D MetabolismDrug Effects On Bone DensityOsteoclast InhibitionVitamin D Analog TherapyVitamin D Effects On BoneVitamin D InsufficiencyVitamin D PhysiologyVitamin D SynthesisVitamin D-mediated Mineral Regulation
We have examined several analogs of 1alpha,25-dihydroxyvitamin D(3) [1,25-(OH)(2)D(3)] in an animal model of osteoporosis (ovariectomized rats) to identify a compound with a greater therapeutic range than 1,25-(OH)(2)D(3) for treatment of this bone disease. Here, we report that one analog, Ro-26-9228, had a bone-protecting effect but did not induce hypercalcemia at a wide concentration range. Analysis of biochemical markers and the bone histomorphometry of analog-treated rats suggested that Ro-26-9228 acted by inhibiting bone resorption and increasing the number of differentiated osteoblasts. To determine the basis for the segregation between hypercalcemia and bone-protecting action, we examined gene expression in tissues that regulate calcium homeostasis. We found that 1,25-(OH)(2)D(3) induced 24-hydroxylase mRNA expression in the duodena of ovariectomized rats, but Ro-26-9228 did not. Furthermore, in the duodena of intact animals, 1,25-(OH)(2)D(3) induced a significant increase in calbindin D 9K and plasma membrane calcium pump 1 mRNAs, but Ro-26-9228 had no effect on these mRNAs. On the other hand, the osteoblast-specific gene products osteocalcin and osteopontin were significantly up-regulated in trabecular bone by both the natural hormone and Ro-26-9228. Further investigation of gene-regulatory events in trabecular bone revealed that both 1,25-(OH)(2)D(3) and Ro-26-9228 up-regulated TGF beta1 and beta2 mRNAs. We concluded that the unique properties of Ro-26-9228 include preferential gene regulation in osteoblasts over duodenum and effective induction of growth factors in bone.
43
Osteoporosis Prevention, Diagnosis, and Therapy
JAMA · 2001 · 5.5K citations
Makoto Noda, Robert L. Vogel, Ann Marie Craig et al. · Proceedings of the National Academy of Sciences · 1990 · 467 citations